Towards personalized medicine with iPS cell technology: a case report of advanced systemic mastocytosis with associated eosinophilia

Affiliations

• ¹ Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University Medical School, Aachen, Germany.
• ² Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.
• ³ Institute for Cell and Tumor Biology, RWTH Aachen University Medical School, Aachen, Germany.
• ⁴ Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
• ⁵ Center for Integrated Oncology, Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.
• ⁶ Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
• ⁷ Institute for Human Genetics, RWTH Aachen University Hospital, Aachen, Germany.
• ⁸ Institute for Biomedical Engineering, Department of Cell Biology, RWTH Aachen University Medical School, Aachen, Germany. martin.zenke@rwth-aachen.de.
• ⁹ Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany. martin.zenke@rwth-aachen.de.
• ¹⁰ Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany. martin.zenke@rwth-aachen.de.
• ¹¹ Center for Integrated Oncology, Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany. martin.zenke@rwth-aachen.de.